Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Dhanvantri Jeevan RekhaBOM:531043 +3.67%63 PB Ratio is 1.09 as of Aug. 15, 2026, which is 54% above its 10-year median of 0.71. GuruFocus rates BOM:531043 with a GF Score™ of 63/100 and a GF Value™ of ₹25.21 (Modestly Overvalued). The stock has 3 warning signs investors should review. Among 610 Healthcare Providers & Services companies, Dhanvantri Jeevan Rekha ranks better than 77.54% on this metric.
The historical rank and industry rank for Dhanvantri Jeevan Rekha's PB Ratio or its related term are showing as below:
BOM:531043'
s PB Ratio Range Over the Past 10 Years
Min: 0.17 Med: 0.71 Max: 2.54
Current: 1.1
During the past 13 years, Dhanvantri Jeevan Rekha's highest PB Ratio was 2.54. The lowest was 0.17. And the median was 0.71.
BOM:531043's PB Ratio is ranked better than 77.54% of 610
companies
in the Healthcare Providers & Services industry
Industry Median: 2.02
vs BOM:531043: 1.10
During the past 12 months, Dhanvantri Jeevan Rekha's average Book Value Per Share Growth Rate was 3.70% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 4.10% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 2.80% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was -0.10% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Dhanvantri Jeevan Rekha was 16.90% per year. The lowest was -5.40% per year. And the median was 4.10% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Dhanvantri Jeevan Rekha's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dhanvantri Jeevan Rekha PB Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Dhanvantri Jeevan Rekha's PB Ratio distribution charts can be found below:
* The bar in red indicates where Dhanvantri Jeevan Rekha's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Dhanvantri Jeevan Rekha (BOM:531043) has a PB Ratio of 1.09 as of Aug. 15, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Dhanvantri Jeevan Rekha and its competitors. This is 54% above median its historical median of 0.71. Over the past decade, Dhanvantri Jeevan Rekha's PB Ratio has ranged from 0.17 to 2.54. According to the industry distribution chart, Dhanvantri Jeevan Rekha ranks #137 out of 610 companies in the Healthcare Providers & Services industry, placing it in the top 22.5%.
Is Dhanvantri Jeevan Rekha's PB Ratio too high?
Dhanvantri Jeevan Rekha's current PB Ratio of 1.09 is 54% above median its 10-year median of 0.71. Over the past 10 years, this metric has ranged from a low of 0.17 to a high of 2.54. The Healthcare Providers & Services industry median PB Ratio is 2.02. Dhanvantri Jeevan Rekha's value of 1.09 is 46% below this industry median. Based on the distribution chart, Dhanvantri Jeevan Rekha ranks #137 out of 610 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Dhanvantri Jeevan Rekha has a GF Score™ of 63/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Dhanvantri Jeevan Rekha's PB Ratio compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Dhanvantri Jeevan Rekha ranks #137 out of 610 companies for PB Ratio. This places Dhanvantri Jeevan Rekha in the top 23% of its industry — outperforming the majority of peers. The industry median PB Ratio is 2.02. Dhanvantri Jeevan Rekha's value of 1.09 is 46% below this benchmark. Historically, Dhanvantri Jeevan Rekha's own PB Ratio has ranged from 0.17 to 2.54 over the past decade. While the company's 10-year median is 0.71 vs. the industry median of 2.02, Dhanvantri Jeevan Rekha has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Healthcare Providers & Services company?
The median PB Ratio among Healthcare Providers & Services companies is 2.02, based on 610 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Dhanvantri Jeevan Rekha's current PB Ratio of 1.09 is 46% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Dhanvantri Jeevan Rekha and its competitors. For the Healthcare Providers & Services industry, the median PB Ratio is 2.02 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dhanvantri Jeevan Rekha's current PB Ratio is 1.09, which is 54% above median its own 10-year median of 0.71. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dhanvantri Jeevan Rekha stock overvalued right now?
Based on GuruFocus' analysis, Dhanvantri Jeevan Rekha (BOM:531043) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹25.21, compared to a current price of ₹27.99 — trading 11% above its estimated fair value. The current PB Ratio is 1.09, which is 54% above median its 10-year median of 0.71 and 46% below the Healthcare Providers & Services industry median of 2.02. Dhanvantri Jeevan Rekha's overall GF Score™ is 63/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Dhanvantri Jeevan Rekha (BOM:531043), the current PB Ratio is 1.09 as of Aug. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Dhanvantri Jeevan Rekha (BOM:531043) Overvalued in 2026?
Based on GuruFocus' analysis, Dhanvantri Jeevan Rekha stock appears to be overvalued.
The current stock price of ₹27.99 is trading 11% above its estimated GF Value™ of ₹25.21.
GuruFocus considers Dhanvantri Jeevan Rekha to be Modestly Overvalued.
Key valuation signals for BOM:531043:
PB Ratio: 1.09 (54% above median its 10-year median of 0.71)
GF Value™: ₹25.21 vs. price of ₹27.99 (11% above fair value)
Industry Position: 46% below the Healthcare Providers & Services median (#137 of 610)
No single metric tells the full story. See the BOM:531043 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Dhanvantri Jeevan Rekha Ltd is engaged in providing diagnostic and therapeutic services and has extended its scope of diagnostic and hospital services by providing a fully operational Cath Lab, catering to higher end needs of the cardiac patients including Angiography, Angioplasty, Pacemaker Implantation, Valvuloplasty etc. The hospital has expanded its services to include a wide range of specialties such as Cardiology, Neurology, Orthopedics, Radiology, Gastroenterology, General Surgery, Urology, and General Medicine.
63GF Score
Get the complete analysis for BOM:531043
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:531043 has been successfully added to your 
